{"id":"https://openalex.org/W7127044367","doi":"https://doi.org/10.3389/fphar.2026.1748399","title":"Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial","display_name":"Evaluation of trimetazidine in alleviating paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial","publication_year":2026,"publication_date":"2026-02-02","ids":{"openalex":"https://openalex.org/W7127044367","doi":"https://doi.org/10.3389/fphar.2026.1748399","pmid":"https://pubmed.ncbi.nlm.nih.gov/41704280","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12907368"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1748399","doi":"https://doi.org/10.3389/fphar.2026.1748399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1748399","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1748399/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1748399/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5124708071","display_name":"Asmaa N. Iqbal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Asmaa N. Iqbal","raw_affiliation_strings":["Clinical Pharmacy Department, Faculty of Pharmacy, Minia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Faculty of Pharmacy, Minia University","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036490274","display_name":"Fatma Mohammed Mady","orcid":"https://orcid.org/0000-0002-2865-145X","observed_orcids":["https://orcid.org/0000-0002-2865-145X"]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Fatma M. Mady","raw_affiliation_strings":["Pharmaceutics Department, Faculty of Pharmacy, Minia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Department, Faculty of Pharmacy, Minia University","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001600569","display_name":"Eman Mohamed Sadek","orcid":"https://orcid.org/0000-0002-5447-6034","observed_orcids":["https://orcid.org/0000-0002-5447-6034"]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Eman Mohamed Sadek","raw_affiliation_strings":["Clinical Pharmacy Department, Faculty of Pharmacy, Minia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Faculty of Pharmacy, Minia University","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058418880","display_name":"Noha M. Abdullah","orcid":"https://orcid.org/0000-0002-5076-2762","observed_orcids":["https://orcid.org/0000-0002-5076-2762"]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Noha M. Abdullah","raw_affiliation_strings":["Department of Clinical Pathology, Faculty of Medicine, Minia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pathology, Faculty of Medicine, Minia University","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001433694","display_name":"Ahmad Mostafa Abdel-Azeez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I89466785","display_name":"Minia University","ror":"https://ror.org/02hcv4z63","country_code":"EG","type":"education","lineage":["https://openalex.org/I89466785"]}],"countries":["EG"],"is_corresponding":false,"raw_author_name":"Ahmad Mostafa Abdel-Azeez","raw_affiliation_strings":["Department of Clinical Oncology, Faculty of Medicine, Minia University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Faculty of Medicine, Minia University","institution_ids":["https://openalex.org/I89466785"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054880337","display_name":"Eman Shorog","orcid":"https://orcid.org/0000-0003-0763-1510","observed_orcids":["https://orcid.org/0000-0003-0763-1510"]},"institutions":[{"id":"https://openalex.org/I82952536","display_name":"King Khalid University","ror":"https://ror.org/052kwzs30","country_code":"SA","type":"education","lineage":["https://openalex.org/I82952536"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Eman Shorog","raw_affiliation_strings":["Department of Clinical Pharmacy, College of Pharmacy, King Khalid University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, College of Pharmacy, King Khalid University","institution_ids":["https://openalex.org/I82952536"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042032786","display_name":"Engy A. Wahsh","orcid":"https://orcid.org/0000-0001-6359-5011","observed_orcids":["https://orcid.org/0000-0001-6359-5011"]},"institutions":[{"id":"https://openalex.org/I4210165376","display_name":"October 6 University","ror":"https://ror.org/05y06tg49","country_code":"EG","type":"education","lineage":["https://openalex.org/I4210165376"]}],"countries":["EG"],"is_corresponding":true,"raw_author_name":"Engy A. Wahsh","raw_affiliation_strings":["Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacy Department, Faculty of Pharmacy, October 6 University","institution_ids":["https://openalex.org/I4210165376"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042032786"],"corresponding_institution_ids":["https://openalex.org/I4210165376"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":2.4016,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.82769208,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":95},"biblio":{"volume":"17","issue":null,"first_page":"1748399","last_page":"1748399"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trimetazidine","display_name":"trimetazidine","score":1.0},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9139999747276306},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.8820000290870667},{"id":"https://openalex.org/keywords/chemotherapy-induced-neurotoxicity","display_name":"chemotherapy-induced neurotoxicity","score":0.8799999952316284},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9900000095367432},{"id":"https://openalex.org/keywords/nerve-growth-factor","display_name":"nerve growth factor","score":0.8640000224113464},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.9649999737739563},{"id":"https://openalex.org/keywords/paresthesia","display_name":"paresthesia","score":0.7609999775886536},{"id":"https://openalex.org/keywords/dysesthesia","display_name":"dysesthesia","score":0.9599999785423279},{"id":"https://openalex.org/keywords/peripheral-motor-neuropathy","display_name":"peripheral motor neuropathy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9002000093460083},{"id":"https://openalex.org/C2777927741","wikidata":"https://www.wikidata.org/wiki/Q674703","display_name":"Trimetazidine","level":2,"score":0.8370000123977661},{"id":"https://openalex.org/C2779901536","wikidata":"https://www.wikidata.org/wiki/Q945238","display_name":"Peripheral neuropathy","level":3,"score":0.7421000003814697},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.715399980545044},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6425999999046326},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6018000245094299},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4318999946117401},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3666999936103821},{"id":"https://openalex.org/C46762472","wikidata":"https://www.wikidata.org/wiki/Q178648","display_name":"Peripheral","level":2,"score":0.3409000039100647},{"id":"https://openalex.org/C2779289229","wikidata":"https://www.wikidata.org/wiki/Q17153857","display_name":"Chemotherapy-induced peripheral neuropathy","level":4,"score":0.32359999418258667},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.28029999136924744},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.271699994802475},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.26089999079704285},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25850000977516174}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1748399","doi":"https://doi.org/10.3389/fphar.2026.1748399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1748399","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1748399/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmid:41704280","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41704280","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pubmedcentral.nih.gov:12907368","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12907368/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:14e217f264734fc2af44a1b9d5f9cf74","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/14e217f264734fc2af44a1b9d5f9cf74","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1748399","doi":"https://doi.org/10.3389/fphar.2026.1748399","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1748399","pdf_url":"https://public-pages-files-2025.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1748399/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F33954902","display_name":"Deanship of Scientific Research, King Khalid University","ror":null},{"id":"https://openalex.org/F4320324433","display_name":"King Khalid University","ror":"https://ror.org/052kwzs30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7127044367.pdf","grobid_xml":"https://content.openalex.org/works/W7127044367.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W2077717033","https://openalex.org/W2081507075","https://openalex.org/W2096491215","https://openalex.org/W2105258029","https://openalex.org/W2115147276","https://openalex.org/W2126550106","https://openalex.org/W2142922236","https://openalex.org/W2317683134","https://openalex.org/W2409479160","https://openalex.org/W2744178041","https://openalex.org/W2746890116","https://openalex.org/W2770256141","https://openalex.org/W2895210343","https://openalex.org/W2909345532","https://openalex.org/W2966437865","https://openalex.org/W2973865014","https://openalex.org/W2999735518","https://openalex.org/W3015025259","https://openalex.org/W3037189796","https://openalex.org/W3106967305","https://openalex.org/W3128832279","https://openalex.org/W3196241326","https://openalex.org/W4205239469","https://openalex.org/W4205580827","https://openalex.org/W4255762755","https://openalex.org/W4281783296","https://openalex.org/W4308157563","https://openalex.org/W4313394127","https://openalex.org/W4315433419","https://openalex.org/W4323668161","https://openalex.org/W4377010611","https://openalex.org/W4377989001","https://openalex.org/W4381510349","https://openalex.org/W4383059243","https://openalex.org/W4385830633","https://openalex.org/W4386843596","https://openalex.org/W4389919152","https://openalex.org/W4392561414","https://openalex.org/W4401365161","https://openalex.org/W4402155363","https://openalex.org/W4406569719","https://openalex.org/W4407607475","https://openalex.org/W4407870211","https://openalex.org/W4408275105","https://openalex.org/W4415137435"],"related_works":["https://openalex.org/W7134255232","https://openalex.org/W4385410081","https://openalex.org/W4403521638","https://openalex.org/W4377010611","https://openalex.org/W4413414491","https://openalex.org/W4392772792","https://openalex.org/W4403198008","https://openalex.org/W6920975939","https://openalex.org/W4323668161","https://openalex.org/W7164850847"],"abstract_inverted_index":{"Background:":[0],"Paclitaxel-induced":[1],"peripheral":[2,31,63,154,174,187,248],"neuropathy":[3,64,95,176,189,249],"is":[4],"a":[5,221,239],"frequent":[6,203],"chemotherapy":[7,271],"complication":[8],"that":[9],"causes":[10],"nerve":[11,131,228],"damage":[12],"and":[13,126,137,152,180,241,266],"profoundly":[14],"reduces":[15],"patients'":[16],"quality":[17,112,198],"of":[18,28,49,56,61,93,113,119,149,199],"life.":[19],"Despite":[20],"extensive":[21],"preclinical":[22],"evidence":[23],"supporting":[24],"the":[25,47,53,59,91,98,116,160,205,210,217],"neuroprotective":[26],"potential":[27],"trimetazidine":[29,50,79,161,211,218],"against":[30],"neuropathy,":[32],"its":[33],"clinical":[34],"efficacy":[35],"remains":[36],"unexplored.":[37],"Objectives:":[38],"This":[39],"proof-of-concept":[40],"randomized":[41,75],"controlled":[42],"trial":[43],"aimed":[44],"to":[45,76,164,209,262],"investigate":[46],"effect":[48],"administered":[51],"during":[52],"early":[54,246],"phase":[55],"treatment":[57],"on":[58],"incidence":[60,92,148],"paclitaxel-induced":[62,94,247],"in":[65,159,169,196,204,226,250],"patients":[66],"with":[67,166,257],"non-metastatic":[68],"breast":[69,251],"cancer.":[70],"Methods:":[71],".":[72],"Patients":[73],"were":[74,139],"receive":[77],"either":[78],"35":[80],"mg":[81],"once":[82],"daily":[83],"or":[84],"placebo":[85],"alongside":[86],"standard":[87],"care.":[88],"Measurements":[89],"included":[90],"assessed":[96],"by":[97],"National":[99],"Cancer":[100,120],"Institute's":[101],"Common":[102],"Terminology":[103],"Criteria":[104],"for":[105,186,244],"Adverse":[106],"Events":[107],"(NCI-CTCAE)":[108],"version":[109],"5.0,":[110],"patient":[111],"life":[114,200],"via":[115],"Functional":[117],"Assessment":[118],"Therapy/Gynecologic":[121],"Oncology":[122],"Group-Neurotoxicity":[123],"(FACT-GOG-Ntx)":[124],"subscale,":[125],"exploratory":[127],"serum":[128,227],"biomarkers,":[129],"specifically":[130],"growth":[132,229],"factor":[133,230],"(NGF)":[134],"levels.":[135],"Neuropathy":[136],"biomarkers":[138],"evaluated":[140],"over":[141],"an":[142],"8-week":[143],"period.":[144],"Main":[145],"Results:":[146],"The":[147],"grade":[150],"2":[151],"3":[153],"neuropathies":[155],"was":[156,201],"significantly":[157,222],"lower":[158],"group":[162,207,212,219],"compared":[163,208],"controls,":[165],"notable":[167],"reductions":[168],"paresthesia":[170],"(p":[171,177,182,190,213,233],"=":[172,178,183,191,214,234],"0.037),":[173],"motor":[175],"0.004),":[179],"dysesthesia":[181],"0.045),":[184],"except":[185],"sensory":[188],"0.152).":[192],"Clinically":[193],"significant":[194],"worsening":[195],"neuropathy-related":[197],"more":[202],"control":[206],"0.001).":[215],"Additionally,":[216],"exhibited":[220],"greater":[223],"percentage":[224],"increase":[225],"from":[231],"baseline":[232],"0.003).":[235],"Conclusion:":[236],"Trimetazidine":[237],"offers":[238],"safe":[240],"effective":[242],"option":[243],"mitigating":[245],"cancer":[252],"patients.":[253],"Further":[254],"large-scale":[255],"studies":[256],"longer":[258],"follow-up":[259],"are":[260],"warranted":[261],"confirm":[263],"these":[264],"findings":[265],"explore":[267],"effects":[268],"across":[269],"different":[270],"regimens.":[272],"Clinical":[273],"Trial":[274],"Registration:":[275],"https://clinicaltrials.gov/study/NCT06459193,":[276],"identifier":[277],"NCT06459193.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-02-03T00:00:00"}